Ravi, Rajani <br/><br/>
Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.  [electronic resource] 

 -  Cancer research  Dec 2004 
 - 9105-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-04-2488  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--pathology<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins<br/>Camptothecin--administration & dosage<br/>Colonic Neoplasms--drug therapy<br/>Drug Synergism<br/>Female<br/>HCT116 Cells<br/>Humans<br/>Irinotecan<br/>Janus Kinase 2<br/>Liver Neoplasms--drug therapy<br/>Membrane Glycoproteins--administration & dosage<br/>Mice<br/>Mice, Nude<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Proteins--metabolism<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-bcl-2--biosynthesis<br/>TNF-Related Apoptosis-Inducing Ligand<br/>Topoisomerase I Inhibitors<br/>Transfection<br/>Tumor Necrosis Factor-alpha--administration & dosage<br/>Tumor Suppressor Protein p53--genetics<br/>X-Linked Inhibitor of Apoptosis Protein<br/>Xenograft Model Antitumor Assays<br/>bcl-X Protein